CLINUVEL Expands Pharmaceutical Portfolio

MELBOURNE, Australia, Nov. 08, 2021 (Globalrelease Wire) — CLINUVEL has expanded its pharmaceutical development portfolio with NEURACTHEL®, novel formulations of the melanocortin adrenocorticotropic hormone (ACTH). The Company has secured supply …